CompuGroup stock holds steady as investors wait for late July earnings
Published on 08/22/2026 at 11:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CompuGroup Medical SE & Co. KGaA (ISIN DE000A288904) stock is trading steadily in the mid-teens in EUR as investors look ahead to the next earnings release scheduled for July 30, 2026, according to recent market data as of June 21, 2026.
Market snapshot and valuation context
Recent quote data for CompuGroup Medical on the London listing under ticker 0MSD shows the shares at 16.22 EUR as of June 21, 2026, with the same value marked as the previous close for that session. The stock has traded within a 52-week range from 16.22 EUR to 28.05 EUR, indicating that the current level is aligned with the lower end of its one-year trading band.
Based on the latest figures compiled as of June 21, 2026, CompuGroup Medical carries a market capitalization of 1.23 billion EUR. At the current share price of 16.22 EUR and trailing earnings per share of 0.54, the implied price-to-earnings ratio stands at a little above 30 times, highlighting a valuation that reflects expectations for continued digital health growth rather than deep value positioning.
Recent earnings, dividend and ownership structure
The latest release noted for CompuGroup Medical is dated May 29, 2026, which included updated earnings metrics for the most recent trailing period and an EPS of 0.54 on a trailing twelve month basis. While full quarterly breakdowns are not detailed in the same overview, the persistence of this EPS figure into mid-2026 underlines that profitability has stabilized at this level ahead of the late July report.
CompuGroup Medical currently offers an annual dividend of 0.50 EUR per share, which equates to a dividend yield of 3.08 percent at the 16.22 EUR share price. This yield figure compares favorably with many broader European health care and technology names that often carry lower cash payouts, suggesting that the stock combines digital health exposure with a modest income component.
Ownership data as of the latest compiled reporting shows 51.73 million common shares outstanding, with mutual funds and ETFs holding 785,060 shares, equal to 1.52 percent of the float. Other institutional investors account for 34.38 million shares or 66.45 percent of the total, while public companies and retail investors hold 16.57 million shares or 32.03 percent. The total market value associated with these holdings is reported at 1.42 billion EUR, with the largest single holder listed at 21,642,300 shares and a stake of 41.83 percent, underscoring a concentrated shareholder base typical for founder- or core-investor-led German mid caps.
Earnings date and expectations for July 30, 2026
The current overview flags July 30, 2026 as the next earnings date for CompuGroup Medical, positioning the release late in the month and likely covering the latest interim period of 2026. For investors, that timing matters because the share price of 16.22 EUR sits close to the 52-week low of 16.22 EUR and offers potential for a reaction once fresh revenue, margin and cash flow metrics are disclosed.
With a market capitalization of 1.23 billion EUR aligned against trailing EPS of 0.54 and a dividend yield of 3.08 percent, the July 30, 2026 report will help clarify whether current earnings and cash distributions can support a rerating towards the upper half of the 16.22 EUR to 28.05 EUR range or whether the stock will remain anchored near its recent lows. If management confirms growth in digital health revenues and maintains or increases the current 0.50 EUR dividend, that could strengthen the case for a multiple closer to peers in European health care technology.
Analysts and institutional investors will also watch for any change in the share count or ownership profile from the current 51.73 million shares and concentrated top holder position. Stability here, combined with solid operational figures, may support a more constructive long-term view on CompuGroup Medical, while any signals of dilution or weaker profitability would likely weigh on sentiment given the already demanding earnings multiple.
Digital health solutions as a core driver
A key pillar of CompuGroup Medical’s business model is its portfolio of software and digital solutions for health care providers, pharmacies and laboratories. These solutions enable electronic patient records, practice management, billing and communication across the health care system and are typically sold on a recurring license or subscription basis, creating a foundation for predictable revenue streams.
For retail investors, the appeal of CompuGroup Medical lies in the intersection of technology and health care. The company’s software helps physicians and hospitals manage clinical workflows and patient data, while its communication tools connect different actors in the health care ecosystem. As health systems across Europe and other regions digitize records and workflows, demand for such integrated solutions tends to grow, supporting the earnings and dividend metrics referenced in current data.
Implementation of digital health platforms can also provide operating leverage. Once core products are developed and widely deployed, incremental customers and modules often carry high margins. If the upcoming July 30, 2026 earnings release confirms that revenue tied to software and digital services continues to expand faster than costs, the current trailing EPS of 0.54 could move higher, which in turn would lower the effective price-to-earnings ratio from the current level above 30 times.
Stock level and investor angle
CompuGroup Medical shares, quoted at 16.22 EUR as of June 21, 2026, sit right at the floor of the reported 52-week range that extends up to 28.05 EUR. This positioning means that any positive surprise in earnings, guidance or dividend policy on July 30, 2026 would come from a low base within the stock’s historical band.
Conversely, with the current valuation still implying an earnings multiple above 30 times on trailing EPS of 0.54 and a market cap of 1.23 billion EUR, investors will scrutinize the upcoming report for confirmation that digital health momentum and recurring revenue justify such a ratio. If results show that earnings growth is limited or margins compress, the market could reassess that multiple even at a price anchored around the 16.22 EUR level.
As of now, the combination of a 3.08 percent dividend yield, concentrated institutional ownership representing 66.45 percent of the shares and a low point in the 52-week range sets the stage for a pivotal late July update. Market participants who focus on digital health names will likely compare CompuGroup Medical’s figures and valuation with other software-oriented health care stocks to gauge relative opportunity and risk.
Representative product in CompuGroup’s portfolio
Within its product universe, a representative example is its practice management and electronic health record software used by physicians in outpatient settings. This type of solution allows doctors to manage patient appointments, clinical documentation, prescriptions and billing from a single platform, integrating laboratory results and communication with other providers.
For patients, such platforms can mean smoother scheduling, reduced paperwork and better continuity of care as information flows more efficiently between different providers. For medical practices, they can reduce administrative burden and help ensure compliance with regulatory requirements for data security and record keeping. Over time, growth in adoption of these platforms contributes to the recurring revenue that supports CompuGroup Medical’s trailing EPS of 0.54 and the dividend payout of 0.50 EUR per share at a 3.08 percent yield.
Closing view on CompuGroup stock
CompuGroup Medical stock, trading at 16.22 EUR as of June 21, 2026, reflects a market capitalization of 1.23 billion EUR and a trailing EPS of 0.54, implying an earnings multiple above 30 times at present levels. With the next earnings date set for July 30, 2026 and a dividend of 0.50 EUR per share yielding 3.08 percent, the late July update will be central in determining whether the shares can move away from the lower bound of their 16.22 EUR to 28.05 EUR 52-week range.
Fact box
Company: CompuGroup Medical SE & Co. KGaA
ISIN: DE000A288904
Ticker: 0MSD
Exchange: London (secondary listing in EUR)
Price (as of June 21, 2026): 16.22 EUR
Market cap: 1.23 billion EUR (as of June 21, 2026)
Sector / Industry: Health care technology / digital health software
Index membership: Not part of major US indexes; listed within European health care and technology benchmarks
Next earnings date: July 30, 2026
